[1] | Sakellariou P, Valente A, Carrillo AE, et al. Chronic l-menthol-induced browning of white adipose tissue hypothesis: A putative therapeutic regime for combating obesity and improving metabolic health. Med Hypotheses 2016 Aug; 93: 21-6. |
[2] | Moretti E, Gonnelli S, Campagna M, et al. Influence of Helicobacter pylori infection on metabolic parameters and body composition of dyslipidemic patients. Intern Emerg Med. 2014 Oct; 9 (7): 767-72. |
[3] | Aksoy H, Sebin SO. H. pylori and cardiovascular disease. Gen Med 2015; S1: 1. [Open Access] |
[4] | Parikh Y, Mason M, Williams K. Researchers' perspectives pediatric obesity research participant recruitment. Clin Transl Med 2016 Dec; 5 (1): 20. Epub 2016 Jun 23. |
[5] | Lee JE, Pope Z, Gao Z. The Role of Youth Sports in Promoting Children's Physical Activity and Preventing Pediatric Obesity: A Systematic Review. Behav Med 2016 Jun 23: 0. [Epub ahead of print] |
[6] | Jolfaie NR, Rouhani MH, Surkan PJ, et al. Rice Bran Oil Decreases Total and LDL Cholesterol in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. Horm Metab Res 2016 Jun 16. [Epub ahead of print] |
[7] | Xiao C, Dash S, Morgantini C, et al. Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol. Diabetes 2016 Jul; 65 (7): 1767-78. |
[8] | Grammer T, Kleber M, Silbernagel G, et al. Residual risk: The roles of triglycerides and high density lipoproteins. Dtsch Med Wochenschr 2016 Jun; 141 (12): 870-7. |
[9] | Farinha P, Gascoyne RD. Helicobacter pylori and MALT Lymphoma. Gastroenterology 2005 May; 128 (6): 1579-605. |
[10] | Nasrat AM, Nasrat SAM, Nasrat RM, et al. Misconception and misbehavior towards Helicobacter pylori is leading to major spread of illness. Gen Med 2015; S1 (002). [Open Access] |
[11] | Katulanda P, Sheriff MH, Matthews DR. The diabetes epidemic in Sri Lanka-a growing problem. Ceylon Med J 2006 Mar; 51(1): 26-8. |
[12] | Wissow LS. Diabetes, poverty and Latin America. Patient Educ Couns 2006 May; 61(2): 169-70. Epub 2006 Apr 18. |
[13] | Einecke D. Like a tsunami: diabetes wave floods the whole world. MMC 2006 Apr 6; 148(14): 4-6. |
[14] | Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. N Med 2006 Jan; 12(1): 62-6. |
[15] | Reddy KS, Naik N, Prabhakaran D. Hypertension in developing world: a consequence of progress. Curr Cardiol Rep 2006; 8 (6): 399-404. |
[16] | Hossain P, Kawar B, El Nahas M. Obesity and diabetes in developing world-a growing challenge. N Engl J Med 2007 Jan18; 356 (3): 213-5. |
[17] | Xu MY, Liu L, Yuan BS, et al. Association of obesity with Helicobacter pylori infection: A retrospective study. World J Gastroenterol 2017 Apr 21; 23 (15): 2750-2756. |
[18] | Abadi ATB. Obesity and Helicobacter pylori: An undefined association. Obesity (Silver Spring) 2017 Jun; 25 (6): 981. Epub 2017 May 5. |
[19] | Moran-Lev H, Lubetzky R, Mandel D, et al. Inverse Correlation between Helicobacter pylori Colonization and Pediatric Overweight: A Preliminary Study. Child Obes 2017 May 1. doi: 10.1089/chi.2016.0275. [Epub ahead of print] |
[20] | Vafaeimanesh J, Bagherzadeh M, Mirzaei A, et al. Effect of Helicobacter pylori on metabolic syndrome parameters in diabetic patients. Gastroenterol Hepatol Bed Bench 2016 Dec; 9 (Suppl 1): S36-S41. |
[21] | Chen LW, Chien CY, Hsieh CW, et al. The Associations between Helicobacter pylori Infection, Serum Vitamin D, and Metabolic Syndrome: A Community-Based Study. Medicine (Baltimore) 2016 May; 95 (18): e3616. doi: 10.1097/MD. 0000000003616. |
[22] | Kassir R, Lointier P, Phelip JM, et Barrett's Oesophagus and Oesophageal Carcinogenesis Following Obesity Surgery: Helicobacter Pylori Must Be Eradicated?. Obes Surg 2017 Jun 28. doi: 10.1007/s11695-017-2785-4. [Epub ahead of print] |
[23] | Danciu M, Simion L, Poroch V. The role of histological evaluation of Helicobacter pylori infection in obese patients referred to laparoscopic sleeve gastrectomy. Rom J Morphol Embryol 2016; 57 (4): 1303-1311. |
[24] | Kim TJ, Lee H, Kang M, et al. Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease. Sci Rep 2016 Nov 28; 6: 38015. doi: 10.1038/srep38015. |
[25] | Pohjanen VM, Koivurova OP, Niemelä SE, et al. Role of Helicobacter pylori and interleukin 6 -174 gene polymorphism in dyslipidemia: a case-control study. BMJ Open 2016 Jan 18; 6 (1): e009987. doi: 10.1136/bmjopen-2015-009987. |
[26] | Chen Z, Xu C, Luo L, et al. Helicobacter pylori infection and gastric mucosa change and blood-lipid in people undergoing the physical examination in Changsha. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2014 Mar; 39 (3): 265-9. |
[27] | Nasrat SAM, Randa MN, Nasrat MN, et al. The dramatic spread of diabetes mellitus worldwide and influence of Helicobacter pylori. General Med. 2015; 3 (1): 159-62. |
[28] | Bulut Y, Agacayak A, Karlidag D, et al. Association of CagA+ Helicobacter pylori with adenotonsillar hypertrophy. Tohoku J Exp Med. 2006 Jul; 209 (3): 229-33. |
[29] | Vijayvergiya R, Vadivelu R. Role of Helicobacter pylori infection in pathogenesis of atherosclerosis. World J Cardiol 2015 Mar 26; 7 (3): 134-43. |
[30] | Buzás GM. Metabolic consequences of Helicobacter pylori infection and eradication. World J Gastroenterol 2014 May 14; 20 (18): 5226-34. |
[31] | Sharma V, Aggarwal A. Helicobacter pylori: Does it add to risk of coronary artery disease. World J Cardiol 2015 Jan 26; 7 (1): 19-25. |
[32] | Rogha M, Dadkhah D, Pourmoghaddas Z, et al. Association of helicobacter pylori infection with severity of coronary heart disease. ARYA Atheroscler 2012 Winter; 7 (4): 138-41. |
[33] | Rogha M, Nikvarz M, Pourmoghaddas Z. Is helicobacter pylori infection a risk factor for coronary heart disease?. ARYA Atheroscler 2012 Spring; 8 (1): 5-8. |
[34] | Nasrat AM, Nasrat SAM, Nasrat RM, et al. The definitive eradication of Helicobacter pylori from the colon. Gen Med 2015; S1: 1. [Open Access] |
[35] | Nasrat RM, Nasrat MM, Nasrat AM, et al. Improvement of idiopathic cardiomyopathy after colon clear. J Cardiol Res 2015. [Open Access] |
[36] | Nasrat AM, Nasrat RM, Nasrat MM. Frequency of leukemia during late decades may indicate that the anti-Helicobacter pylori antibiotic strategy was a therapeutic mistake. Am J Med Med Sci 2017; 7 (3): 103-107. [Open Access] |
[37] | Hughes NJ, Clayton CL, Chalk PA, et al. Helicobacter pylori porCDAB oorDABC genes encode distinct pyruvate: flavodoxin and 2-oxoglutarate: acceptor oxidoreductases which mediate electron transport to NADP. J Bacteriol 1998 Mar; 180(5): 1119-28. |
[38] | Berg JM, Tymoczko JL, Stryer L. Biochemistry. WH Freeman and Company. 2002; 5th Ed: 480. |
[39] | Mendz GL, Hazell SL. Fumarate catabolism in Helicobacter pylori. Biochem Mol Biol Int. 1993 Oct; 31 (2): 325-32. |
[40] | Mendz GL, Hazell SL, van Gorkom L. Pyruvate metabolism in Helicobacter pylori. Arch Microbiol. 1994; 162(3):187-92. |
[41] | Jang SH, Lee H, Kim JS, et al. Association between Helicobacter pylori Infection and Cerebral Small Vessel Disease. Korean J Fam Med 2015 Sep; 36 (5): 227-32. |